Showing results (1-10 of 355) with videos related to
Sort By:
Pageof 36
Current Molecular Medicine|June 25, 2005
Telomere dynamics in hematopoietic stem cellsStefan Zimmermann, Uwe M MartensCell and Tissue Research|October 26, 2007
Telomeres, senescence, and hematopoietic stem cellsStefan Zimmermann, Uwe M MartensInternational Journal of Oncology|April 6, 2005
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell lineMilena Pantic, Stefan Zimmermann, Cornelius F Waller, et al.Journal of Proteomics|August 24, 2013
Quantitative proteomic profiling of tumor cell response to telomere dysfunction using isotope-coded protein labeling (ICPL) reveals interaction network of candidate senescence markersMartin L Biniossek, André Lechel, K Lenhard Rudolph, et al.Stem Cells (Dayton, Ohio)|September 3, 2004
Effects of telomerase modulation in human hematopoietic progenitor cellsStefan Zimmermann, Stefanie Glaser, Robin Ketteler, et al.Proteomics|January 10, 2009
Proteomic profiling of tumor cells after induction of telomere dysfunctionStefan Zimmermann, Martin L Biniossek, Milena Pantic, et al.Blood|October 28, 2004
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532Hesham El-Daly, Miriam Kull, Stefan Zimmermann, et al.Proteomics|October 17, 2009
Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunctionStefan Zimmermann, Martin L Biniossek, Christian Maurer, et al.Artificial Organs|February 24, 2005
On the regenerative capacity of human skeletal muscleAnton Wernig, Ralf Schäfer, Ulrich Knauf, et al.Cancers|November 27, 2021
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid TumorsLionel Larribère, Uwe M MartensPageof 36